http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022164134-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4579923d27661dd10fea760553ccf784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83b60d3511666dbe07e2cc6edab7f9ae
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
filingDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b08f9a65b74929c239b34e1c4431402d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa822696290fa8fb56d1733fde89a043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1449d3249a11cbbb962ef047693e8f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4b90d0a082f5cc76bfa71c05dd4e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c7f9cdea45717fb6a4ca157a2c5a3c
publicationDate 2022-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2022164134-A
titleOfInvention A therapeutic agent for vascular tumors and vascular malformations
abstract Kind Code: A1 A drug effective in treating vascular tumors and vascular malformations is provided. Kind Code: A1 A therapeutic agent for vascular tumor and vascular malformation comprising sirolimus as an active ingredient, which is orally administered or administered through a tube at a starting dose shown below according to the weight and age of a subject. (1) Subjects weighing 30 kg or more: 1.4 mg/day as sirolimus (2) Subjects weighing less than 30 kg and less than 3 months old 0.02 mg/kg/day as sirolimus 3 months or more and less than 6 months 0.04 mg/day as sirolimus 0.06 mg/kg/day as sirolimus 6 months or more and less than 12 months of age 0.08 mg/kg/day as sirolimus 12 months or more of age However, the upper limit of the starting dose is 1.4 mg/day as sirolimus per subject . [Selection figure] None
priorityDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56718
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID47396
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID100235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID324254
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID100235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452451264
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2475
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID419455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426352332
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153274811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100139219
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22391770

Total number of triples: 40.